The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
Open accessAbstract
We summarize significant changes in pathologic classification of lung cancer resulting from the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) lung adenocarcinoma classification. The classification was developed by an international core panel of experts representing IASLC, ATS, and ERS with oncologists/pulmonologists, pathologists, radiologists, molecular biologists, and thoracic surgeons. Because 70% of patients with lung cancer present with advanced stages, a new approach to small biopsies and cytology with specific terminology and criteria focused on the need for distinguishing squamous cell carcinoma from adenocarcinoma and on molecular testing for EGFR mutations and ALK rearrangement. Tumors previously classified as non–small-cell carcinoma, not otherwise specified, because of the lack of clear squamous or adenocarcinoma morphology should be classified further by using a limited immunohistochemical workup to preserve tissue for molecular testing. The terms “bronchioloalveolar carcinoma” and “mixed subtype adenocarcinoma” have been discontinued. For resected adenocarcinomas, new concepts of adenocarcinoma in situ and minimally invasive adenocarcinoma define patients who, if they undergo complete resection, will have 100% disease-free survival. Invasive adenocarcinomas are now classified by predominant pattern after using comprehensive histologic subtyping with lepidic, acinar, papillary, and solid patterns; micropapillary is added as a new histologic subtype with poor prognosis. Former mucinous bronchioloalveolar carcinomas are now called “invasive mucinous adenocarcinoma.” Because the lung cancer field is now rapidly evolving with new advances occurring on a frequent basis, particularly in the molecular arena, this classification provides a much needed standard for pathologic diagnosis not only for patient care but also for clinical trials and TNM classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citationAnaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Mitsudomi, T., Morita, S., Yatabe, Y., Negoro, S., Okamoto, I., Tsurutani, J., Seto, T., Satouchi, M., Tada, H., Hirashima, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70364-x · Cited by 4,090
Zhou, C., Wu, Y.-L., Chen, G., Feng, J., Liu, X.-Q., Wang, C., Zhang, S., Wang, J., Zhou, S., Ren, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70184-x · Cited by 4,081
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatzemeier, U., Digumarti, R., Zukin, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0375 · Cited by 3,203
Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937
Ciuleanu, T., Brodowicz, T., Zielinski, C., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y.-L., Bover, I., Begbie, S., Tzekova, V., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61497-5 · Cited by 1,111
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationWeiss, J., Sos, M. L., Seidel, D., Peifer, M., Zander, T., Heuckmann, J. M., Ullrich, R. T., Menon, R., Maier, S., Soltermann, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001451 · Cited by 821
Self-citationWarth, A., Muley, T., Meister, M., Stenzinger, A., Thomas, M., Schirmacher, P., Schnabel, P. A., Budczies, J., Hoffmann, H., & Weichert, W. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2185 · Cited by 692
Scagliotti, G., Hanna, N., Fossella, F., Sugarman, K., Blatter, J., Peterson, P., Simms, L., & Shepherd, F. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0232 · Cited by 690
Russell, P. A., Wainer, Z., Wright, G. M., Daniels, M., Conron, M., & Williams, R. A. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318221f701 · Cited by 624
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Hammerman, P. S., Sos, M. L., Ramos, A. H., Xu, C., Dutt, A., Zhou, W., Brace, L. E., Woods, B. A., Lin, W., Zhang, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0005 · Cited by 482
Self-citationEML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Inamura, K., Takeuchi, K., Togashi, Y., Nomura, K., Ninomiya, H., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Soda, M., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815e8b60 · Cited by 467
Yoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Fujimoto, M., Kawakami, F., Tsuruyama, T., Travis, W. D., Date, H., & Haga, H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182769aa8 · Cited by 436
Self-citationMino-Kenudson, M., Chirieac, L. R., Law, K., Hornick, J. L., Lindeman, N., Mark, E. J., Cohen, D. W., Johnson, B. E., Jänne, P. A., Iafrate, A. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2845 · Cited by 423
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Dutt, A., Ramos, A. H., Hammerman, P. S., Mermel, C., Cho, J., Sharifnia, T., Chande, A., Tanaka, K. E., Stransky, N., Greulich, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020351 · Cited by 369
Sica, G., Yoshizawa, A., Sima, C. S., Azzoli, C. G., Downey, R. J., Rusch, V. W., Travis, W. D., & Moreira, A. L. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181e4ee32 · Cited by 325
Self-citationTargeting Anaplastic Lymphoma Kinase in Lung Cancer
Shaw, A. T., & Solomon, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1591 · Cited by 308
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
Yoshida, A., Tsuta, K., Nakamura, H., Kohno, T., Takahashi, F., Asamura, H., Sekine, I., Fukayama, M., Shibata, T., Furuta, K., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182233e06 · Cited by 280
Bejarano, P. A. (2011) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(10)79482-2 · Cited by 273
Thunnissen, E., Beasley, M. B., Borczuk, A. C., Brambilla, E., Chirieac, L. R., Dacic, S., Flieder, D., Gazdar, A., Geisinger, K., Hasleton, P., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.106 · Cited by 237
Self-citationRekhtman, N., Brandt, S. M., Sigel, C. S., Friedlander, M. A., Riely, G. J., Travis, W. D., Zakowski, M. F., & Moreira, A. L. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820517a3 · Cited by 236
Self-citationEGFR Mutations in Lung Adenocarcinomas
Li, A. R., Chitale, D., Riely, G. J., Pao, W., Miller, V. A., Zakowski, M. F., Rusch, V., Kris, M. G., & Ladanyi, M. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070178 · Cited by 214
Self-citationFinberg, K. E., Sequist, L. V., Joshi, V. A., Muzikansky, A., Miller, J. M., Han, M., Beheshti, J., Chirieac, L. R., Mark, E. J., & Iafrate, A. J. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060182 · Cited by 214
McLeer-Florin, A., Moro-Sibilot, D., Melis, A., Salameire, D., Lefebvre, C., Ceccaldi, F., de Fraipont, F., Brambilla, E., & Lantuejoul, S. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182381535 · Cited by 205
Self-citationPathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift
Travis, W. D., Rekhtman, N., Riley, G. J., Geisinger, K. R., Asamura, H., Brambilla, E., Garg, K., Hirsch, F. R., Noguchi, M., Powell, C. A., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d57f6e · Cited by 191
Self-citationInvasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma
Borczuk, A. C., Qian, F., Kazeros, A., Eleazar, J., Assaad, A., Sonett, J. R., Ginsburg, M., Gorenstein, L., & Powell, C. A. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318190157c · Cited by 186
Kadota, K., Suzuki, K., Kachala, S. S., Zabor, E. C., Sima, C. S., Moreira, A. L., Yoshizawa, A., Riely, G. J., Rusch, V. W., Adusumilli, P. S., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.58 · Cited by 174
Self-citationGirard, N., Ostrovnaya, I., Lau, C. C., Park, B. J., Ladanyi, M., Finley, D. J., Deshpande, C. G., Rusch, V. W., Orlow, I., Travis, W. D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0594 · Cited by 156
Self-citationHistologic features are important prognostic indicators in early stages lung adenocarcinomas
Yim, J. H., Zhu, L., Chiriboga, L. A., Watson, H. N., Goldberg, J. D., & Moreira, A. L. (2006) · Modern Pathology · doi:10.1038/modpathol.3800734 · Cited by 147
Jokoji, R., Yamasaki, T., Minami, S., Komuta, K., Sakamaki, Y., Takeuchi, K., & Tsujimoto, M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.081166 · Cited by 135
Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers
Finley, D. J., Yoshizawa, A., Travis, W. D., Zhou, Q. C., Seshan, V., Bains, M. S., Flores, R. M., Rizk, N. P., Rusch, V. W., & Park, B. J. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c814c5 · Cited by 128
Self-citationCore Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational Analysis
Solomon, S. B., Zakowski, M. F., Pao, W. J., Thornton, R. H., Ladanyi, M., Kris, M. G., Rusch, V. W., & Rizvi, N. A. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.2858 · Cited by 127
Yoshida, A., Tsuta, K., WATANABE, S.-I. I., Sekine, I., Fukayama, M., Tsuda, H., Furuta, K., & Shibata, T. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.09.013 · Cited by 118
Warth, A., Stenzinger, A., von Brünneck, A., Goeppert, B. F., Cortis, J., Petersen, I., Hoffmann, H., Schnabel, P. A., & Weichert, W. (2012) · European Respiratory Journal · doi:10.1183/09031936.00219211 · Cited by 113
Shim, H. S., Lee, D. H., Park, E. J., & Kim, S. H. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2010-0493-oa · Cited by 105
Casali, C., Rossi, G., Marchioni, A., Sartori, G., Maselli, F., Longo, L., Tallarico, E., & Morandi, U. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60ff5 · Cited by 95
Wislez, M., Antoine, M., Baudrin, L., Poulot, V., Neuville, A., Pradere, M., Longchampt, É., Isaac, S., Lebitasy, M.-P., & Cadranel, J. L. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.05.021 · Cited by 85
Ou, S. I., & Zell, J. A. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181b28fb9 · Cited by 80
New Strategies for Treatment of ALK-Rearranged Non–Small Cell Lung Cancers
Sasaki, T., & Janne, P. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1404 · Cited by 79
Lim, E. H., Zhang, S.-L., Li, J., Yap, W. S., Howe, T.-C., Tan, B. P., Lee, Y.-S., Wong, D., Khoo, K., Seto, K., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181913e28 · Cited by 77
Copin, M., Buisine, M., Leteurtre, E., Marquette, C., Porte, H., Aubert, J., Gosselin, B. H., & Porchet, N. (2001) · Human Pathology · doi:10.1053/hupa.2001.22752 · Cited by 76
Hata, A., Katakami, N., Fujita, S., Kaji, R., Imai, Y., Takahashi, Y., Nishimura, T., Tomii, K., & Ishihara, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e2a2bc · Cited by 76
Syrigos, K. N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R. G., Simms, L., Sugarman, K. P., Visseren‐Grul, C., & Scagliotti, G. V. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp392 · Cited by 67
on behalf of the Pulmonary Pathology Working Group of the German Society of Pathology, Warth, A., Cortis, J., Fink, L., Fisseler‐Eckhoff, A., Geddert, H., Hager, T., Junker, K., Kayser, G., Kitz, J., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1263-6 · Cited by 65
Sterlacci, W., Savic, S., Schmid, T. A., Oberaigner, W., Auberger, J., Fiegl, M., & Tzankov, A. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp77kmkjxnmpms · Cited by 54
Rossi, G., Papotti, M. G., Barbareschi, M., Graziano, P., & Pelosi, G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0515 · Cited by 43
Bracci, P. M., Sison, J. D., Hansen, H. M., Walsh, K. M., Quesenberry, C. P., Raz, D. J., Wrensch, M., & Wiencke, J. K. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825aba47 · Cited by 18
Cited by
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Self-citationCancer Progress and Priorities: Lung Cancer
Schabath, M. B., & Cote, M. L. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0221 · Cited by 1,160
Gridelli, C., Rossi, A., Carbone, D. P., Guarize, J., Karachaliou, N., Mok, T., Petrella, F., Spaggiari, L., & Rosell, R. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.9 · Cited by 1,083
Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer: A Review
Arbour, K. C., & Riely, G. J. (2019) · JAMA · doi:10.1001/jama.2019.11058 · Cited by 1,060
Self-citation
Metadata
- Authors
- Travis, W. D., Brambilla, E., & Riely, G. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-03-10
- Volume
- 31
- Issue
- 8
- Pages
- 992-1001
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2045883724
- Cited by
- 599
- References
- 53
- FWCI
- 47.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.